AM-Pharma racks up $176m

AM-Pharma B.V., a Dutch developer of treatment for acute kidney injury, has raised additional funding of $52 million, increasing its recent total tally to $176 million.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to read this article and more for free.

Share this